Reverse Mergers with Non-SPAC Shell Companies

Introduction

A reverse merger with a non-SPAC shell takes a private operating company public by acquiring a publicly-listed shell that has no operating business. The structure resembles a SPAC merger but uses a non-SPAC shell with different regulatory treatment, listing standards, and post-merger trading characteristics. This is the smallest of the principal IPO alternatives and serves a narrow set of issuers for whom the cost and time savings outweigh the structural drawbacks. This article walks through how reverse mergers work, the seasoning rules that constrain the path, and the December 2025 Nasdaq rule changes.

The mechanical structure of a reverse merger is straightforward but produces meaningfully different post-merger trading dynamics than either an IPO or a SPAC merger.

The Shell Company

A non-SPAC shell company is a publicly-listed entity that has no operating business and typically holds minimal assets. The shell may have emerged from a prior business that was wound down, from a corporate restructuring, or from a deliberate shell-company formation. Unlike a SPAC, a non-SPAC shell does not have a trust account holding capital for an eventual merger; the shell is simply a publicly-listed entity that the operating company can acquire.

The Acquisition Mechanics

The private operating company acquires the shell through a stock-for-stock merger, with the shell's existing shareholders receiving a small portion of the combined company's equity. The operating company's pre-merger shareholders receive the remainder. The "reverse" in reverse merger reflects that the operating company is structurally acquiring the shell but, from a securities-law perspective, the shell company is the surviving registrant; the operating company effectively becomes the shell company's new business.

Post-Merger Listing

After the merger, the combined company often trades on whichever venue the shell was listed on, which historically has been OTC Markets or one of the smaller exchanges rather than NYSE or Nasdaq. Companies seeking listing on a major exchange post-reverse-merger must meet the seasoning rules described below, which typically take at least one year to satisfy.

The principal regulatory constraint on reverse mergers is the seasoning rules under NYSE and Nasdaq listing standards.

What Seasoning Requires

To list a reverse-merged company on NYSE or Nasdaq, the rules require the post-merger entity to have been traded on the OTC market or an exchange for at least one year, to have timely filed all required periodic financial reports (including at least one annual report) with the SEC for the prior year, and to have maintained a minimum $4 closing price for no less than 30 of the most recent 60 trading days both at the time of the listing application and at the time of listing approval. The cumulative effect is that a reverse-merged company typically cannot list on a major exchange immediately after the merger; it must spend at least a year trading on OTC Markets first.

What Seasoning Is Designed to Stop

The seasoning rules exist to address the historical pattern of reverse mergers being used to bring lower-quality issuers public quickly with minimal disclosure. The rules effectively force reverse-merged companies to demonstrate post-merger compliance and trading viability before accessing the major exchanges. Issuers that cannot satisfy the seasoning requirements remain on OTC Markets indefinitely, with limited institutional interest and trading liquidity.

December 2025 Nasdaq Changes

The December 2025 Nasdaq rule changes specifically excluded certain de-SPAC transactions from the seasoning requirements: a de-SPAC with a formerly OTC-traded SPAC (rather than an actively-listed SPAC) was previously subject to the seasoning rules; under the new rules, IPO-type listing standards apply instead. The change made the de-SPAC path more attractive relative to a non-SPAC reverse merger, further narrowing the use cases for the latter structure.

Seasoning Rules (Reverse Merger Listing)

The NYSE and Nasdaq listing standards that require a reverse-merged company to demonstrate post-merger trading and compliance history before listing on a major exchange. The rules typically require at least one year of OTC or exchange trading post-merger, timely filing of all required SEC reports, and a minimum $4 closing price maintained for 30 of the most recent 60 trading days. The seasoning rules are the principal regulatory constraint that distinguishes reverse mergers from SPAC mergers, where the seasoning rules generally do not apply.

The reverse merger structure fits a narrow set of issuers for whom the structural drawbacks are acceptable.

Micro-Cap and Smaller-Cap Issuers

The structure works for issuers below a certain size where traditional IPO economics do not work. An IPO that would raise less than $50 million to $100 million in primary proceeds typically struggles to attract bookrunner attention and institutional demand at scale. Reverse mergers provide a path to public markets for these smaller issuers without the underwriter syndicate the IPO requires.

Specific Sector Applications

Reverse mergers see continued use in micro-cap technology, biotech, and resource-extraction sectors where IPO economics are particularly difficult. Tech and biotech reverse mergers are typically pre-revenue or pre-clinical; resource-extraction reverse mergers are typically development-stage companies needing public-market access for permit financing.

Cost-Conscious Issuers

Total reverse-merger costs are meaningfully lower than even a SPAC merger, with combined legal, audit, and advisory fees often under $1 million for smaller deals. The cost difference matters most for the smallest issuers where the absolute amounts represent a meaningful fraction of available capital.

For micro-cap issuers below the threshold where IPO economics work, the reverse merger remains a real path; for everyone else, the seasoning rules and reputational drag eliminate it from serious consideration. A different alternative entirely, common among private-equity-backed companies that genuinely do not know whether the better outcome is public-market exit or strategic sale, is to prepare for both at once. Dual-track processes are the next subject.